Isocarboxazid (Marplan) Tablet Shortage

Source: FDA · United States

Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.

The FDA reports a current shortage of Isocarboxazid Tablet, with availability noted from one manufacturer.

FDA drug-shortage notice: what the record actually shows

This notice was issued by FDA on June 15, 2026 and geographically references United States. Its severity classification of "low" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.

A quick skim tells you whether this affects you directly; a closer read tells you more. Check the scope, the source, and how recent the record is, then weigh it against related notices rather than treating any single one as a trend.

Before acting, the primary agency source is available to check alongside this summary. Its related labels are drug-shortage, fda, medication, Isocarboxazid.

What's in Shortage

Isocarboxazid Tablet (brand name: MARPLAN), dosage form Tablet, therapeutic category Psychiatry. Shortage status is Current. First posted 04/16/2026, last updated 06/03/2026.

Which Manufacturers Are Affected

  • Lifsa Drugs LLC: Available. Presentation: Marplan, Tablet, 10 mg, 100 count bottle (NDC 72336-032-01). Contact: 833.627.0070.

Why There's a Shortage

No specific reason was provided in the source data.

What Patients Should Do

Patients should talk to their pharmacist, ask about alternatives if needed, and contact the manufacturer directly. Always consult your healthcare provider before making any changes to your medication. Do not stop taking prescribed medication without professional medical advice.

Source

FDA Drug Shortage Database

Original source: FDA Official Notice ↗

All Drug Shortages →

Comparable nationwide notices (length or severity timing) 8

Two Areazine-derived peer sets for this FDA drug-shortage notice: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.

Common Questions

Common questions about this FDA drug-shortage notice.

What is this FDA drug-shortage notice about?
The FDA reports a current shortage of Isocarboxazid Tablet, with availability noted from one manufacturer.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How severe is this alert?
This alert is classified as "low" severity. No immediate action required, but stay aware.
What area is affected?
This alert affects United States. Check with FDA for the most current geographic scope.
Where can I find more Drug Shortages updates?
Browse the full Drug Shortages feed on Areazine at areazine.com/drug-shortages/ for the latest updates from FDA and other agencies.